These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3877538)

  • 1. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
    Bird HA; Allen JG; Dixon JS; Wright V
    Br J Rheumatol; 1985 Nov; 24(4):351-6. PubMed ID: 3877538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
    Bird HA; Allen JG; Dixon JS; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):47-52. PubMed ID: 3879830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma.
    Day RO; Williams KM; Graham S; Handel M
    Arthritis Rheum; 1991 Jun; 34(6):751-60. PubMed ID: 2053921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratio.
    Hinderling PH; Hartmann D; Crevoisier C; Moser U; Heizmann P
    Ther Drug Monit; 1988; 10(3):250-60. PubMed ID: 3262939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of food and of antacid on the single oral dose pharmacokinetics of tenoxicam.
    Francis RJ; Dixon JS; Lowe JR; Harris PA
    Eur J Drug Metab Pharmacokinet; 1985; 10(4):309-14. PubMed ID: 3879481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and synovial fluid concentrations of piroxicam during prolonged treatment with piroxicam pivalic ester.
    Chérié Lignière G; Montagnani G; Alberici M; Acerbi D
    Arzneimittelforschung; 1987 May; 37(5):560-3. PubMed ID: 3619977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of tenoxicam in patients with impaired renal function.
    Horber FF; Guentert TW; Weidekamm E; Heizmann P; Descoeudres C; Frey FJ
    Eur J Clin Pharmacol; 1986; 29(6):697-701. PubMed ID: 3709612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of tenoxicam.
    Nilsen OG
    Clin Pharmacokinet; 1994 Jan; 26(1):16-43. PubMed ID: 8137596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and synovial fluid concentrations of isoxicam in meniscectomized patients.
    Ballerini R; Casini A; Chinol M; Mannucci C; Melani F; Ungar F
    Drugs Exp Clin Res; 1985; 11(8):517-21. PubMed ID: 3841790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-beta-cyclodextrin.
    Bannwart B; Bertin P; Péhourcq F; Schaeverbeke T; Gillet P; Lefrançois G; Trèves R; Dehais J; Netter P; Gaucher A
    Int J Clin Pharmacol Ther; 2001 Jan; 39(1):33-6. PubMed ID: 11204935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with tenoxicam: a review.
    Bird HA
    Scand J Rheumatol Suppl; 1987; 65():102-6. PubMed ID: 3317799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of tenoxicam in healthy human volunteers.
    Heintz RC; Guentert TW; Enrico JF; Dubach UC; Brandt R; Jeunet FS
    Eur J Rheumatol Inflamm; 1984; 7(2):33-44. PubMed ID: 6336292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of tenoxicam on glibornuride kinetics and response.
    Stoeckel K; Trueb V; Dubach UC; Heintz RC; Ascalone V; Forgo I; Hennes U
    Br J Clin Pharmacol; 1985 Feb; 19(2):249-54. PubMed ID: 3157397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
    Deneke J; Luckow V; Guserle R; Pässler HH
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis.
    Trnavská Z; Trnavský K; Zlnay D
    Eur J Clin Pharmacol; 1984; 26(4):457-61. PubMed ID: 6734706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of tenoxicam (Tilcotil, Mobiflex) at two doses against ibuprofen in rheumatoid arthritis.
    Bird HA; Hill J; Lowe JR; Wright V
    Eur J Rheumatol Inflamm; 1984; 7(2):28-32. PubMed ID: 6400518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
    Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Articular diffusion of meloxicam after a single oral dose: relationship to cyclo-oxygenase inhibition in synovial cells.
    Lapicque F; Vergne P; Jouzeau JY; Loeuille D; Gillet P; Vignon E; Thomas P; Velicitat P; Türck D; Guillaume C; Gaucher A; Bertin P; Netter P
    Clin Pharmacokinet; 2000 Nov; 39(5):369-82. PubMed ID: 11108435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single and multiple oral dose pharmacokinetics of tenoxicam in the elderly.
    Bird HA; Francis RJ; Le Gallez P; Hill J; Dixon JS; Allen JG; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):60-9. PubMed ID: 3879831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma tenoxicam concentrations after single and multiple oral doses.
    Crevoisier C; Heizmann P; Forgo I; Dubach UC
    Eur J Drug Metab Pharmacokinet; 1989; 14(1):23-7. PubMed ID: 2788089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.